Tag: CureVac

EU takes up option to buy 150 million more Moderna Covid-19 vaccines – ET HealthWorld

Brussels: The European Union has decided to take up an option under a supply contract with drugmaker Moderna that allows the bloc to order 150 million additional Covid-19 vaccines produced by the U.S. biotech firm, the EU Commission said on Tuesday. The announcement comes a week after CureVac, a German biotech firm, said its Covid-19 […]

Read More

जर्मन बायोटेक की कोविड-19 वैक्सीन ह्यूमन ट्रायल के आखिरी चरण में फेल

जर्मन बायोटेक क्योरवैक की विकसित प्रायोगिक कोविड-19 वैक्सीन तीसरे चरण के मानव परीक्षण में नाकाम साबित हुई है. ये किसी भी वैक्सीन उम्मीदवार की अंतिम चरण में पहली बड़ी नाकामी है. क्योरवैक ने कहा कि अंतरिम परीक्षण के नतीजे में वैक्सीन का असर 47 फीसद रहा जो परीक्षण के उद्देश्य से कम और अमेरिकी नियामकों […]

Read More

WHO chief scientist disappointed by CureVac trial – ET HealthWorld

Geneva- The World Health Organization‘s chief scientist said on Friday that results from the CureVac COVID-19 vaccine‘s initial trial were disappointing. German biotech firm CureVac’ vaccine proved only 47% effective in an initial trial read-out. “It was disappointing to see the results from CureVac,” the WHO’s Soumya Swaminathan told a news conference. (Reporting by Mike […]

Read More

Germany’s CureVac faces delay on Covid vaccine trial – ET HealthWorld

Frankfurt: A coronavirus vaccine being developed by Germany‘s CureVac is facing delays in its late-stage trial as it has been struggling with the wait for enough participants to catch Covid, officials informed on Friday. CureVac initially expected to seek European approval for its jab in the second quarter, with Germany pencilling in 1.4 million doses […]

Read More

UK begins ‘booster’ shot trial of 7 different Covid-19 vaccines – ET HealthWorld

Britain launched a nationwide study on Wednesday to explore whether giving a third dose “booster” shot of coronavirus vaccines would be safe and effective in extending immune protection against Covid-19. The trial, which aims to recruit nearly 3,000 participants, will look at seven different Covid-19 shots, some of which are already approved by regulators and […]

Read More

The pan-European consortium seeks big pharma partner for Covid-19 shot – ET HealthWorld

A pan-European consortium developing a Covid-19 vaccine is in talks with big pharma to support the late-stage development of its shot and ramp up manufacturing, the head of German biotech firm Leukocare told Reuters. Leukocare is working with Italy’s ReiThera and Belgium’s Univercells on a vaccine based on a so-called non-replicating adenoviral vector, the same […]

Read More

GSK, CureVac partnership eyes Covid-19 vaccine against multiple variants – ET HealthWorld

FRANKFURT: Britain’s GlaxoSmithKline and German biotech firm CureVac struck a 150 million euro ($180 million) deal to develop next-generation vaccines against Covid-19 that target several variants in one product. In a joint statement on Wednesday, the partners said they were targeting a possible launch in 2022. GSK, which holds a stake in CureVac, will also […]

Read More